UFC Flyweight Sarah Frota Suspended 2 Years for Positive Steroid Test

Sarah Frota has been suspended two years by USADA after testing positive for steroids, the anti-doping organization announced Tuesday.

The USADA statement is as follows:

Frota Lima, 32, tested positive for multiple stanozolol metabolites, including 16α-hydroxystanozolol, 3’,16-dihydroxystanozolol, and 4β,16-dihydroxystanozolol, as the result of an in-competition urine sample she provided on July 27, 2019 at UFC 240 Edmonton, where she lost by technical knockout. Stanozolol is a non-Specified Substance in the class of Anabolic Agents and prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency Prohibited List.

Frota Lima’s two-year period of ineligibility, the standard sanction for a non-Specified Substance under the UFC Anti-Doping Policy, began on July 27, 2019, the date her positive sample was collected. The athlete’s positive test also falls under the jurisdiction of the Edmonton Combative Sports Commission, which has accepted USADA’s resolution of the case and recognized its sanction. Frota Lima has not competed in the UFC since her fight on July 27, 2019.

Frota suffered a second-round TKO loss to Gillian Robertson at UFC 240, the event where she tested positive. According to MMAFighting.com, Frota has been released from her UFC contract. The Brazilian will not be eligible to compete until July 27, 2021.

Frota earned a UFC contract with a first-round knockout victory over Maiara Amanajas dos Santos on the Brazilian edition of Dana White’s Contender Series. She dropped a split verdict to Livinha Souza in her debut before falling to Robertson. The Astra Fight Team representative owns a 9-2 professional mark overall.